Introduction {#s1}
============

Cornelia de Lange Syndrome (CdLS1 MIM 122470) is a developmental multiple congenital anomalies disorder with intellectual disability characterized by distinctive facial features as synophrys with highly arched eyebrows, long eyelashes, short nose with anteverted nares, small widely spaced teeth, microcephaly, pre- and post-natal growth retardation, hirsutism and subtle or evident upper limb defects ([@B1]). Prevalence estimates range from 1:100,000 to 1:10,000 ([@B2], [@B3]) though they precede the finding of the surprisingly high fraction of individuals with somatic mosaicism ([@B4]) and the application of high resolution diagnostic tools, such as deep sequencing on multigene panel/exome or transcript analysis, which all together have enhanced the detection of pathogenic variants. Up to 70% of clinically diagnosed CdLS patients harbor heterozygous pathogenic variants in *NIPBL* gene (OMIM 608667) ([@B5], [@B6]) which encodes a regulatory protein loading the cohesin complex onto sister chromatids. More than 300 pathogenic variants, mostly point mutations, have been found evenly spread across the whole *NIPBL* gene in CdLS patients ([@B4], [@B7]). Frameshift variants, the most prevalent *NIPBL* defects, commonly underlie a severe phenotype, while pathogenic missense variants are often associated to mild disease ([@B8]). Splicing alterations account for 17% *NIPBL* pathogenic variants ([@B9]) but are likely underestimated, as almost all those detected affect canonical splice sites or flanking consensus sequences (LOVD *NIPBL*). A familial case where a canonical *NIPBL* splice variant segregating from a mosaic mother to her son was recently reported to be associated to heterogeneous phenotype expression ([@B10]). The prevalence of pauci-symptomatic *NIPBL-*mutated cases is difficult to estimate as these patients are often overlooked and do not receive molecular diagnosis. A mild CdLS phenotype that retains many characteristic facial features but presents with low grade intellectual disability and minor malformations has been shown to be underpinned by non-canonical splicing variants by Teresa-Rodrigo ([@B11]) who described two intronic *NIPBL* pathogenic variants in two mild CdLS German patients. We herein report on five Italian patients with mild CdLS phenotype, three of whom belonging to the same family, who carry the same branch site substitution detected in one of the two above mentioned mild CdLS patients ([@B11]). This data corroborates the contribution of non-canonical splicing variants to *NIPBL*-caused CdLS and enhances optimization of detection rate in slightly affected subjects who are potential transmitters of the disease.

Case report {#s2}
===========

All five patients from three unrelated families were referred to our lab by experienced clinical geneticists with a diagnostic query of mild CdLS phenotype.

Family 1
--------

Family 1 comprises a female and a male (III-1, III-2) siblings referred at the age of 4 and 2 years, respectively, and their 37 years- old mother (II-3). All subjects displayed mild, but typical signs of CdLS facial gestalt as synophrys, long filtrum, and anterved nostrils (Figures [1A,B](#F1){ref-type="fig"}). Family history recorded similar facial features for II-3\'s paternal aunt (I-3). The clinical diagnosis was supported by neuropsychological assessment of the siblings, evidencing mild to moderate intellectual disability (ID).

![Phenotype and molecular findings of five CdLS patients with the *NIPBL* intronic variant c.5329-15A\>G. **(A)** Pedigrees of family 1 (F1) with three ascertained affected individuals (II-3, III-1, III-2) and one inferred patient and of family 2 (F2) and 3 (F3) sporadic cases. Black symbols are for the CdLS patients, gray symbol for individual with inferred phenotype; black symbol in square brackets indicates an adopted child. **(B)** Facial appearance of F1 sibs and mother and of F2 proband. **(C)** DNA pathogenic variant (cDNA nomenclature). Below each family member the normal ("+") or variant allele (c.5329-15A\>G) is indicated.](fneur-09-00967-g0001){#F1}

Family 2
--------

Proband II-1 is a male child, born to healthy parents (Figure [1A](#F1){ref-type="fig"}) referred at the age of 5 years because of facial gestalt typical of CdLS (Figure [1B](#F1){ref-type="fig"}) and mild psychomotor delay. He was delivered preterm (36+6 weeks of gestational age) by C-section. The neonatal parameters were: length 45 cm, weight 1.840 g, head circumference 29 cm, APGAR score 7/8. He was transferred in NICU for respiratory distress, tachipnoea, and hypoglycaemia.

Postnatally, he demonstrated mild growth restriction for all parameters (head circumference, height and weight) and a mild truncal hypertonia. At the age of 6 months, a lacrimal duct stenosis was diagnosed. At the age of 5 years, weight was 13 kg, height 98.2 cm, head circumference 45 cm, and psychomotor development was mildly delayed. He displayed diffuse hirsutism.

Family 3
--------

The proband II-1 is an adopted girl (Figure [1A](#F1){ref-type="fig"}) referred at age of 10 years for scholar problems and suggestive facial dysmorphisms. Whether she is a sporadic or a familial case cannot thereby be assessed. As shown in Figure [1A](#F1){ref-type="fig"}, CdLS facial gestalt was characterized by synophrys, highly arched eyebrows, short nose with anteverted nares, long philtrum, thin vermilion of the upper lip, high, and arched palate. Table [1](#T1){ref-type="table"} reports for all five patients growth parameters referred to the standard growth charts, at birth and at last clinical evaluation, as well as, feeding problems, developmental milestones and cognitive and behavior impairment. All the patients displayed pre- and post-natal growth delay, craniofacial dysmorphisms and mild psychomotor delay, which raised the clinical suspicion of mild CdLS phenotype. Conversely, other recurrent CdLS signs were absent or underrepresented including gastroesophageal reflux (GER), not observed in any of the patients, hirsutism displayed only by the proband of family 2, and subtle limb anomalies present in the two sporadic cases. As regards intellectual disability, three unrelated patients (III-2 from F1, and the probands of F2, and F3) are ranked borderline, while the mother of family 1 is assessed at the lowest level of normal range for IQ. Slight intra-familial variability is attested by the moderate ID of III-1 from F1; both sibs display behavior anomalies, III-1 is aggressive, hyperactive and more recently hyperphagic, while her brother III-2 shows somnolence, asthenia, and hyperactivity at school.

###### 

Clinical features of five CdLS individuals with NM_133433.3: c.5329-15A\>G *NIPBL* pathogenic variant.

                                              **Family 1**                  **Family 2**                                    **Family 3**                             
  ------------------------------------------- ----------------------------- ----------------------------------------------- -------------- ------------------------- -----------------------------------------------------------------
  Clinical severity                           Moderate                      Mild                                            Mild           Mild                      Mild
  Gender                                      F                             M                                               F              M                         F
  **ANTHROPOMETRIC DATA (BIRTH)**                                                                                                                                    
  Gestational age                             40                            39                                              40             36+6                      39
  Weight (Kg)                                 10 cen                        10 cen                                          \< 3 cen       \< 3 cen                  \< 3 cen
  Length (cm)                                 10 cen                        na                                              na             3 cen                     25 cen
  OFC (cm)                                    \< 3 cen                      na                                              na             \< 3 cen                  \< 3 cen
  IUGR                                        \+                            \+                                              --             \+                        \+
  **ANTHROPOMETRIC DATA**                                                                                                                                            
  Age at last evaluation                      4 years                       2 years 3 months                                37 years       7.5 years                 10 years
  Weight (Kg)                                 10 cen                        \< 3 cen                                        75--90 cen     \< 3 cen                  25 cen
  Length (cm)                                 25 cen                        \< 3 cen                                        10 cen         \< 3 cen                  10 cen
  OFC (cm)                                    na                            \< 3 cen                                        na             \< 3 cen                  10--25 cen
  Postnatal growth retardation                \+                            \+                                              \+             \+                        nd
  Feeding difficulties/swallowing disorders   \+                            --                                              Na             \+                        \+
  GERD                                        --                            --                                              --             na                        --
  Hirsutism                                   --                            --                                              --             ++                        --
  Limb defects                                Hip dysplasia                 center leg la[^a^](#TN1){ref-type="table-fn"}   --             Proximal thumb set        Partial cutaneous 2°-3° toes syndactyly/clinodactyly 4°-5° toes
  **DYSMORPHISMS**                                                                                                                                                   
  Synophrys                                   \+                            \+                                              \+             \+                        \+
  Long philtrum                               \+                            \+                                              \+             \+                        \+
  Anteverted nostrils                         \+                            +/--                                            \+             \+                        \+
  Thin upper lip                              \+                            \+                                              --             --                        \+
  Microretrognathia                           \+                            --                                              --             --                        --
  **DEVELOPMENTAL DELAY**                                                                                                                                            
  Age of walking (months)                     16                            19                                              na             15                        19
  First words (months)                        13--14                        23                                              na             18                        22
  Microcephaly                                \+                            \+                                              +/--           na                        na
  Intellectual disability                     \+                            +/--[^b^](#TN2){ref-type="table-fn"}            --             +/--                      +/--[^c^](#TN3){ref-type="table-fn"}
  Behaviour anomalies                         ++                            \+                                              \+             --                        +/-- (attention deficit disorder)
  Others                                      Mild hypoplasic aortic arch   Scoliosis                                       na             Lacrimal ducts stenosis   Recurrent infections

*Lateralized Asymmetry*.

*70 by Griffith evaluation (borderline range 70--79)*.

*75 by WISC-IV (borderline range 70--79)*.

Materials and methods {#s3}
=====================

Genomic sequencing
------------------

Genomic DNA was extracted from peripheral blood leukocytes using Freedom Evo TECAN extractor. A panel of CdLS genes including *NIPBL* (NM_133433), *SMC1A* (NM_300040), *SMC3* (NM_606062), *HDAC8* (NM_300269), and *RAD21* (NM_606462) was interrogated. Genomic sequencing of whole coding region including 20 nucleotides of flanking intron-exon junctions was performed by Illumina Nextera Rapid Capture Enrichment protocol, following the manifacturer\'s instructions, while the uncovered genomic regions were analyzed by Nextera-XT-Library-prep protocol (Illumina) and Sanger sequencing using the Big Dye Terminator v.3.1 Cycle Sequencing Kit (Applied Biosystems). Intronic *NIPBL* nucleotide variant NM_133433:c.5329-15A \> G was confirmed by PCR with primers for genomic DNA 5′-CACCTGTACTGATTTTTAAGTTAAACTTTGA-3′ (forward strand) and 5′-TTTTCACCAAGAACTCGTAGGATCT-3′ (reverse strand) and Go Taq Hot Start Polymerase (Promega).

cDNA analysis
-------------

Total RNA was extracted from peripheral blood leukocytes using Tempus Spin RNA Isolation Kit (Applied Biosystems) and reverse transcribed to cDNA by SuperScript VILO Kit (Invitrogen). cDNA was amplified by Go Taq Hot Start Polymerase (Promega) and sequenced using the Big Dye Terminator v.3.1 Cycle Sequencing Kit (Applied Biosystems) with primers 5′-TATAGCCCAGTGGTTTCGAG-3′ (forward strand) and 5′-GGTCGACAAAGGACAAATCG-3′ (reverse strand) and run on ABI PRISM 3500 sequencer (Applied Biosystems) according to the manufacture\'s protocol. Electropherograms were compared to *NIPBL* NM_133433 reference sequence.

Molecular characterization
--------------------------

All the five subjects with a suspected mild CdLS clinical diagnosis were found to carry the *NIPBL* non-canonical intronic sequence alteration NC_000005.9 g.37022138 A\>G NM_133433.3:c.5329-15A\>G (Figure [1C](#F1){ref-type="fig"}), characterized only in one German CdLS patient with mild phenotype ([@B11]). Whole *NIPBL* gene coding sequence and intronic flanking regions were sequenced, excluding the occurrence of VUS (variant unknown sequence) or pathogenic variants. No pathogenic variants were disclosed neither in the HDAC8, SMC1, SMC3, and RAD21 gene.

Characterization at transcript level of all five patients using both *ad hoc* designed primers and the primers used by Teresa-Rodrigo et al. evidenced besides the expected wild type (wt) transcript, two aberrant transcripts (a-Tr) which sequences are provided in Figure [2A](#F2){ref-type="fig"}. Namely a-Tr1 is the in frame exon 28 skipped transcript (diagrammed in Figure [2B](#F2){ref-type="fig"}) found in the German patient, leading to the in frame deletion p (Ile1777Arg1809del). We also detected an additional aberrant transcript (a-Tr2), which sequence retains 14 nucleotides of the 3′ terminus of IVS27, downstream the intronic A\>G transition (Figure [2A](#F2){ref-type="fig"}), leading to frame disruption. The c.5329-15A\>G transition affects the recognition of the branch point and the acceptor splice site of intron 27, hence activating a cryptic splice site (diagrammed in Figure [2B](#F2){ref-type="fig"}). The intronic variant changes a-Tr2 coding sequence into (NM_133433):r.5328_5329ins\[5329-14_5329-1;uguuugcuuggcag\], predicting the truncated protein p.(Ile1777CysfsX22).

![**(A,B)** cDNA electropherograms show the wild type transcript (black characters) and two aberrant transcripts, the in frame a-Tr1, skipping exon 28 (green characters) and a-Tr2 retaining 14 nucleotides of IVS28 3\' (purple characters). The intronic "g" replacing "a" hence creating an alternative donor splice site is in red.](fneur-09-00967-g0002){#F2}

The intronic variant has not been found in the consulted GnomAD, ExAC, and Ensemble databases. According to the ACMG criteria the variant herein described may be considered at strong evidence of pathogenicity PS4 ([@B12]), because of its prevalence in CdLS individuals, namely 6 cases including the previously published one ([@B11]) and absence in the control population\'s databases. The cosegregation with the CdLS phenotype within family also features as supporting evidence, PP1 ([@B13]).

According to the cDNA electropherogram in Figure [2A](#F2){ref-type="fig"}, showing the mix of wild type and alternative transcripts, the wild type sequence is prominent.

Discussion {#s4}
==========

We have identified in our CdLS patients cohort five individuals with mild phenotype sharing the same c.5329-15A\>G *NIPBL* intronic variant, which has been reported to date only in one patient ([@B11]). Our findings on three unrelated patients in our cohort of 110 *NIPBL*-mutated cases (2.7%) highlight a mutation hotspot in a non-canonical site of the consensus splice sites ([@B12]). The frequency of deep intronic variants affecting the branch site may be underestimated because both Sanger sequencing and NGS not always disclose sequence changes disrupting splicing. Interestingly, three out of the five investigated Italian CdLS patients belong to the same family (F1) (Figure [1A](#F1){ref-type="fig"}) underlining the yet unreported inheritance of this pathogenic variant and the need of appropriate genetic counseling to families. To date only about a dozen branch site pathogenic variants have been reported ([@B14]).

Although the estimated frequency of *NIPBL* splicing defects is consistent ([@B9], [@B10]), only two non-canonical splice variants are recorded in HGMD database: NM_133433:c.459-9G\>A which effect is only predicted ([@B4]) and the branch site variant NM_133433:c.5329-15A\>G, recurring in our patients and the previously described case ([@B11]). Sequencing of the proband\'s cDNA showed two aberrant transcripts a-Tr1 and a-Tr2, a finding consistent with the frequent detection of multiple mRNA species, widely reported for variants deeply located within an intron as those affecting the branch point ([@B15]).

According to Teresa Rodrigo, the level of total *NIPBL* expression was not significantly decreased in the characterized case, suggesting negligible production of the in frame aTr-1, likely due to minor use of the alternative acceptor splice site. As regards the out frame a-Tr2, found in our cases, it appears remarkably less represented than the wild type transcript, but more represented than a-Tr1 (see Figure [2A](#F2){ref-type="fig"}). Interestingly despite only a tiny fraction of the total *NIPBL* mRNA seems represented by the alternative transcripts, likely undergoing degradation, their occurrence is sufficient for recognition of the CdLS phenotype. In conclusion, our data corroborates the previously reported case with the same branch site pathogenic variant ([@B11]) highlighting the significance and diagnostic impact of non-canonical intronic variants of *NIPBL* gene in CdLS patients and the graded clinical presentation of CdLS with detection of extremely mild adult cases through their progeny ([@B10]). It is well-known that the approximate detection rate of *NIPBL* pathogenic variants (\~70%) also implemented by the recent widespread application of multigene panel and WES NGS ([@B9]), underestimates the fraction of cases with mild phenotype. Our study first reports on a family segregating through two generations an intronic *NIPBL* pathogenic variant and raises the attention on provision of genetic counseling also when mild dysmorphic features and borderline intellectual disability are noted by the clinical geneticist. Mildly affected CdLS subjects are rare ([@B1]) and often they remain molecularly unsolved. Whenever they display suggestive clinical features they should be accurately investigated, also in the non-coding sequence, considering the 50% risk of generating affected progeny ([@B10], [@B16]).

Concluding remarks {#s5}
==================

Two main conclusions may be drawn by the present work.

The first one points to the relevance of deep intronic sequence variations, such as those affecting the branch site as disease causing. Sequencing of non-coding regions should be addressed when the patient\'s phenotype is suggestive of a specific genetic diagnosis. Branch site variants have been rarely described and every further example is instrumental to learn on the multiple consequences of mis-splicing. The second conclusion, inferred by the reported inheritance of Cornelia de Lange resulting from pathogenic variants leading to mis-splicing, underlines the need of detecting the molecular basis of recognizable mild clinical phenotypes to provide genetic counseling to the families.
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